SCHEMBL23319906

SCHEMBL23319906

COc1ccc(-c2ccc(Oc3[nH]nnc3C(=O)O)cc2OC)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAO1 Q9UJM8 5/20 0.44
ALPL P05186 2/20 0.42
PRKAG1 P54619 2/20 0.40
PRKAA1 Q13131 2/20 0.40
PRKAB1 Q9Y478 2/20 0.40
ERN1 O75460 1/20 0.37
FYN P06241 2/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
EGFR P00533 1/20 0.37
MEN1 O00255 1/20 0.36
CASP3 P42574 1/20 0.36
KMT2A Q03164 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
KIT P10721 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31166249 1.00 HAO1 (0.44) HAO1ALPLPRKAG1PRKAA1PRKAB1
SCHEMBL25463830 0.91 RCE1 (0.40) HAO1ALPLERN1FYNMKNK1
SCHEMBL25464365 0.89 HAO1 (0.40) HAO1ALPLPRKAG1PRKAA1PRKAB1
SCHEMBL29968360 0.87 HAO1 (0.50) HAO1ALPLPRKAG1PRKAA1PRKAB1
SCHEMBL23319968 0.87 HAO1 (0.50) HAO1ALPLPRKAG1PRKAA1PRKAB1
SCHEMBL23319889 0.84 HAO1 (0.54) HAO1PRKAG1PRKAA1PRKAB1MKNK1
SCHEMBL31166182 0.83 ALPL (0.42) HAO1ALPLPRKAG1PRKAA1PRKAB1
SCHEMBL23319931 0.83 ALPL (0.42) HAO1ALPLPRKAG1PRKAA1PRKAB1
SCHEMBL23319999 0.80 ALPL (0.43) HAO1ALPLPRKAG1PRKAA1PRKAB1
SCHEMBL23001831 0.78 HAO1 (0.72) HAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS VENTHERA, INC. 2021-12-30 US disclosed
EP-3817816-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS Orfan Biotech Inc. (US) 2021-05-12 EP disclosed
CN-112399873-A Triazole glycolate oxidase inhibitor 奥凡生物科技公司 2021-02-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO HAO1 6/4885ALPL 652/4885PRKAG1 2945/4885
US-20210403439-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO HAO1 6/4885ALPL 652/4885PRKAG1 2945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.